Next Article in Journal
Induced Degradation of Tat by Nucleocapsid (NC) via the Proteasome Pathway and Its Effect on HIV Transcription
Next Article in Special Issue
Oligopeptide M13 Phage Display in Pathogen Research
Previous Article in Journal
Induction of Partial Protection against Foot and Mouth Disease Virus in Guinea Pigs by Neutralization with the Integrin β6-1 Subunit
Viruses 2013, 5(4), 1131-1142; doi:10.3390/v5041131
Article

Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display

1,2,†
, 3,†
, 1
, 4
, 1
, 1,*  and 2,*
Received: 6 February 2013; in revised form: 11 April 2013 / Accepted: 15 April 2013 / Published: 22 April 2013
(This article belongs to the Special Issue Phage Display in Virus Research)
View Full-Text   |   Download PDF [417 KB, uploaded 22 April 2013]   |   Browse Figures
Abstract: Latent Membrane Protein 1 (LMP1) is a primary target for controlling tumorigenesis in Epstein-Barr virus related malignancies; in this study, we aimed to develop a specific antibody against the TES1 domain of the oncogenic LMP1. We screened a full human naïve Fab phage library against TES1 peptide, which consisted of C terminal-activating regions proximal 44 amino acids. After three rounds of panning, enrichment and testing by phage ELISA and further analyzed by DNA sequencing, we selected a phage clone with the highest affinity to LMP1-TES1 and designated it as htesFab. The positive clone was expressed in Escherichia coli and the purified htesFab was characterized for its binding specificity and affinity to LMP1. ELISA, immunofluorescence and FACS analysis confirmed that htesFab could recognize LMP1 TES1 both in vitro and in LMP1 expressing HNE2-LMP1 cells. Furthermore, MTT assay showed that htesFab inhibited the proliferation of HNE2-LMP1 cells in a dose-dependent manner. In summary, this study reported the isolation and characterization of human Fab, which specifically targets the C terminal region/TES1 of LMP1, and has potential to be developed as novel tool for the diagnosis and therapy of Epstein-Barr virus related carcinoma
Keywords: EBV; LMP1; phage antibody library; nasopharyngeal carcinoma; Fab antibody EBV; LMP1; phage antibody library; nasopharyngeal carcinoma; Fab antibody
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Zhang, D.; Mao, Y.; Cao, Q.; Xiong, L.; Wen, J.; Chen, R.; Zhu, J. Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display. Viruses 2013, 5, 1131-1142.

AMA Style

Zhang D, Mao Y, Cao Q, Xiong L, Wen J, Chen R, Zhu J. Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display. Viruses. 2013; 5(4):1131-1142.

Chicago/Turabian Style

Zhang, Dawei; Mao, Yuan; Cao, Qing; Xiong, Lin; Wen, Juan; Chen, Renjie; Zhu, Jin. 2013. "Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display." Viruses 5, no. 4: 1131-1142.


Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert